• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ELMOD2是家族性特发性肺纤维化的一个候选基因。

ELMOD2 is a candidate gene for familial idiopathic pulmonary fibrosis.

作者信息

Hodgson Ulla, Pulkkinen Ville, Dixon Morag, Peyrard-Janvid Myriam, Rehn Marko, Lahermo Paivi, Ollikainen Vesa, Salmenkivi Kaisa, Kinnula Vuokko, Kere Juha, Tukiainen Pentti, Laitinen Tarja

机构信息

Department of Pulmonary Medicine, Helsinki University Central Hospital, Finland.

出版信息

Am J Hum Genet. 2006 Jul;79(1):149-54. doi: 10.1086/504639. Epub 2006 May 9.

DOI:10.1086/504639
PMID:16773575
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1474126/
Abstract

We performed a genomewide scan in six multiplex families with familial idiopathic pulmonary fibrosis (IPF) who originated from southeastern Finland. The majority of the Finnish multiplex families were clustered in the region, and the population history suggested that the clustering might be explained by an ancestor shared among the patients. The genomewide scan identified five loci of interest. The hierarchical fine mapping in an extended data set with 24 families originating from the same geographic region revealed a shared 110 kb to 13 Mb haplotype on chromosome 4q31, which was significantly more frequent among the patients than in population-based controls (odds ratio 6.3; 95% CI 2.5-15.9; P = .0001). The shared haplotype harbored two functionally uncharacterized genes, ELMOD2 and LOC152586, of which only ELMOD2 was expressed in lung and showed significantly decreased messenger-RNA expression in IPF lung (n = 6) when compared with that of healthy lung (n = 7; P = .05). Our results suggest ELMOD2 as a novel candidate gene for susceptibility in familial IPF.

摘要

我们对来自芬兰东南部的六个患有家族性特发性肺纤维化(IPF)的多重家庭进行了全基因组扫描。大多数芬兰多重家庭聚集在该地区,人口历史表明这种聚集可能是由患者之间共享的祖先所解释。全基因组扫描确定了五个感兴趣的基因座。在来自同一地理区域的24个家庭的扩展数据集中进行的分层精细定位显示,4号染色体q31上有一个110 kb至13 Mb的共享单倍型,在患者中比基于人群的对照组中更为频繁(优势比6.3;95%可信区间2.5 - 15.9;P = .0001)。该共享单倍型包含两个功能未明确的基因,即ELMOD2和LOC152586,其中只有ELMOD2在肺中表达,并且与健康肺(n = 7)相比,在IPF肺(n = 6)中其信使核糖核酸表达显著降低(P = .05)。我们的结果表明ELMOD2是家族性IPF易感性的一个新的候选基因。

相似文献

1
ELMOD2 is a candidate gene for familial idiopathic pulmonary fibrosis.ELMOD2是家族性特发性肺纤维化的一个候选基因。
Am J Hum Genet. 2006 Jul;79(1):149-54. doi: 10.1086/504639. Epub 2006 May 9.
2
Nationwide prevalence of sporadic and familial idiopathic pulmonary fibrosis: evidence of founder effect among multiplex families in Finland.散发性和家族性特发性肺纤维化的全国患病率:芬兰多个家族中奠基者效应的证据。
Thorax. 2002 Apr;57(4):338-42. doi: 10.1136/thorax.57.4.338.
3
ELMOD2, a candidate gene for idiopathic pulmonary fibrosis, regulates antiviral responses.ELMOD2,特发性肺纤维化的候选基因,调节抗病毒反应。
FASEB J. 2010 Apr;24(4):1167-77. doi: 10.1096/fj.09-138545. Epub 2009 Dec 4.
4
Familial idiopathic pulmonary fibrosis.家族性特发性肺纤维化。
Adv Exp Med Biol. 2013;788:363-7. doi: 10.1007/978-94-007-6627-3_49.
5
Familial idiopathic pulmonary fibrosis: clinical features and outcome.家族性特发性肺纤维化:临床特征与预后
Chest. 2005 Jun;127(6):2034-41. doi: 10.1378/chest.127.6.2034.
6
Idiopathic pulmonary fibrosis: is it a familial disease?特发性肺纤维化:它是一种家族性疾病吗?
Curr Opin Pulm Med. 2006 Sep;12(5):312-7. doi: 10.1097/01.mcp.0000239546.24831.61.
7
Early interstitial lung disease in familial pulmonary fibrosis.家族性肺纤维化中的早期间质性肺疾病
Am J Respir Crit Care Med. 2007 Oct 1;176(7):698-705. doi: 10.1164/rccm.200702-254OC. Epub 2007 Jul 19.
8
Telomerase mutations in families with idiopathic pulmonary fibrosis.特发性肺纤维化家族中的端粒酶突变
N Engl J Med. 2007 Mar 29;356(13):1317-26. doi: 10.1056/NEJMoa066157.
9
Exome sequencing identifies mutant TINF2 in a family with pulmonary fibrosis.外显子组测序在一个患有肺纤维化的家族中鉴定出突变的TINF2。
Chest. 2015 May;147(5):1361-1368. doi: 10.1378/chest.14-1947.
10
Expression of monocyte chemoattractant protein 1 mRNA in human idiopathic pulmonary fibrosis.人特发性肺纤维化中单核细胞趋化蛋白1信使核糖核酸的表达
Proc Natl Acad Sci U S A. 1992 Jun 15;89(12):5371-5. doi: 10.1073/pnas.89.12.5371.

引用本文的文献

1
The microRNA miR-30a blocks adipose tissue fibrosis accumulation in obesity.微小RNA miR-30a可阻止肥胖症中脂肪组织纤维化的积累。
J Clin Invest. 2025 Jun 5;135(15). doi: 10.1172/JCI175566. eCollection 2025 Aug 1.
2
Persistent microbial infections and idiopathic pulmonary fibrosis - an insight into pathogenesis.持续性微生物感染与特发性肺纤维化——发病机制的深入探讨
Front Cell Infect Microbiol. 2024 Dec 20;14:1479801. doi: 10.3389/fcimb.2024.1479801. eCollection 2024.
3
The Dawn of Precision Medicine in Fibrotic Interstitial Lung Disease.纤维化间质性肺疾病中精准医学的曙光。
Chest. 2025 Apr;167(4):1120-1132. doi: 10.1016/j.chest.2024.10.042. Epub 2024 Nov 8.
4
Revolutionizing the Treatment of Idiopathic Pulmonary Fibrosis: From Conventional Therapies to Advanced Drug Delivery Systems.颠覆特发性肺纤维化治疗模式:从传统疗法到先进药物递送系统。
AAPS PharmSciTech. 2024 Apr 8;25(4):78. doi: 10.1208/s12249-024-02793-y.
5
Precision medicine advances in idiopathic pulmonary fibrosis.特发性肺纤维化的精准医学进展。
EBioMedicine. 2023 Sep;95:104766. doi: 10.1016/j.ebiom.2023.104766. Epub 2023 Aug 23.
6
Idiopathic pulmonary fibrosis and the role of genetics in the era of precision medicine.特发性肺纤维化与精准医学时代遗传学的作用。
Front Med (Lausanne). 2023 Apr 27;10:1152211. doi: 10.3389/fmed.2023.1152211. eCollection 2023.
7
Anti-Myxovirus Resistance Protein-1 Immunoglobulin A Autoantibody in Idiopathic Pulmonary Fibrosis.抗副黏液病毒核蛋白 1 免疫球蛋白 A 自身抗体在特发性肺纤维化中的作用。
Can Respir J. 2022 Mar 29;2022:1107673. doi: 10.1155/2022/1107673. eCollection 2022.
8
The ARF GAPs ELMOD1 and ELMOD3 act at the Golgi and cilia to regulate ciliogenesis and ciliary protein traffic.ARF GAPs ELMOD1 和 ELMOD3 在高尔基体和纤毛上发挥作用,调节纤毛发生和纤毛蛋白运输。
Mol Biol Cell. 2022 Feb 1;33(2):ar13. doi: 10.1091/mbc.E21-09-0443. Epub 2021 Nov 24.
9
Molecular Biomarkers in Idiopathic Pulmonary Fibrosis: State of the Art and Future Directions.特发性肺纤维化的分子生物标志物:现状与未来方向。
Int J Mol Sci. 2021 Jun 10;22(12):6255. doi: 10.3390/ijms22126255.
10
Gene fusion of IL7 involved in the regulation of idiopathic pulmonary fibrosis.IL7 基因融合参与特发性肺纤维化的调控。
Ther Adv Respir Dis. 2021 Jan-Dec;15:1753466621995045. doi: 10.1177/1753466621995045.

本文引用的文献

1
Clinical and pathologic features of familial interstitial pneumonia.家族性间质性肺炎的临床和病理特征
Am J Respir Crit Care Med. 2005 Nov 1;172(9):1146-52. doi: 10.1164/rccm.200408-1104OC. Epub 2005 Aug 18.
2
Familial idiopathic pulmonary fibrosis: clinical features and outcome.家族性特发性肺纤维化:临床特征与预后
Chest. 2005 Jun;127(6):2034-41. doi: 10.1378/chest.127.6.2034.
3
Cis-acting regulatory variation in the human genome.人类基因组中的顺式作用调控变异。
Science. 2004 Oct 22;306(5696):647-50. doi: 10.1126/science.1101659.
4
Genomic variants in exons and introns: identifying the splicing spoilers.外显子和内含子中的基因组变异:识别剪接干扰因素。
Nat Rev Genet. 2004 May;5(5):389-96. doi: 10.1038/nrg1327.
5
Characterization of a common susceptibility locus for asthma-related traits.哮喘相关性状常见易感性位点的特征分析
Science. 2004 Apr 9;304(5668):300-4. doi: 10.1126/science.1090010.
6
Idiopathic pulmonary fibrosis; its occurrence in identical twin sisters.特发性肺纤维化;其在同卵双胞胎姐妹中的发生情况。
Dis Chest. 1950 Oct;18(4):330-44. doi: 10.1016/s0096-0217(15)34710-5.
7
Idiopathic pulmonary fibrosis: current and future treatment options.特发性肺纤维化:当前及未来的治疗选择
Am J Respir Med. 2002;1(3):211-24. doi: 10.1007/BF03256611.
8
Pulmonary fibrosis in families.家族性肺纤维化
Am J Respir Cell Mol Biol. 2003 Sep;29(3 Suppl):S47-50.
9
Missense, nonsense, and neutral mutations define juxtaposed regulatory elements of splicing in cystic fibrosis transmembrane regulator exon 9.错义突变、无义突变和中性突变定义了囊性纤维化跨膜调节因子第9外显子中并列的剪接调控元件。
J Biol Chem. 2003 Jul 18;278(29):26580-8. doi: 10.1074/jbc.M212813200. Epub 2003 May 5.
10
Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.超过15000条全长人类和小鼠cDNA序列的生成与初步分析。
Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):16899-903. doi: 10.1073/pnas.242603899. Epub 2002 Dec 11.